Further cellular assays confirmed that sera from vaccinated mice contain anti-SOST antibodies capable of inhibiting osteoclast activity and promoting osteoblast function, thereby restoring the balance between bone resorption and formation disrupted in osteoporosis. This evidence concerns the gene SOST and osteoporosis.